title: [Amisulpride: a treatment option for psychotic disorders soon to be available in the Netherlands].
abstract: BACKGROUND
  The antipsychotic drug amisulpride has not yet been officially approved for use in the Netherlands, although it is already available in other European countries , including Belgium, the UK and Germany. However, a fast-track procedure has recently been initiated so that amisulpride will soon become available in the Netherlands as well.
  
  
  OBJECTIVE
  To summarise the efficacy and side effects of amisulpride.
  
  
  METHODS
  We discuss the evidence presented in the scientific literature.
  
  
  RESULTS
  The scientific literature assures us that amisulpride is an effective antipsychotic drug with an acceptable range of side-effects. This means that there are two main advantages that ensue from the use of amisulpride: a patient's psychosis is more likely to go into remission and patients are less likely to stop taking the drug.
  
  
  CONCLUSIONS
  The availability of amisulpride in the Netherlands will constitute a valuable addition to the pharmacotherapeutic options for treating psychotic disorders in our county.
authors.forename: C H
authors.initials: CH
authors.lastname: Vinkers
authors.forename: I E
authors.initials: IE
authors.lastname: Sommer
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects / Q000600:supply & distribution / Q000627:therapeutic use*; D006801:Humans; D009426:Netherlands; D011618:Psychotic Disorders / Q000188:drug therapy*; D013469:Sulpiride / Q000009:adverse effects / Q000031:analogs & derivatives / Q000600:supply & distribution / Q000627:therapeutic use*
chemical_list: D014150:Antipsychotic Agents; D013469:Sulpiride